B.K. Mahmoud, et al.
PhytochemistryLetters35(2020)200–205
silica gel CC (Ф = 60 mm, L = 77 cm), using EtOAc-MeOH gradient
mixtures to afford five subfractions. Subfraction E-II-2 was chromato-
graphed on silica gel VLC (Ф = 40 mm, L = 40 cm), which was gra-
diently eluted with DCM-MeOH to give eight subractions, of which
subraction E-II-2-3 was subjected to silica gel CC using DCM-MeOH
(92:8) isocratic elution to give three subfractions, of which the second
subfraction E-II-2-3-2 (0.53 g) was subjected to sephadex LH-20 CC
using MeOH, followed by HPLC purification using H2O-MeOH (95:5)
for 5 min, followed by a linear gradient to 100% MeOH within 55 min
and finally with a further isocratic condition of MeOH for 5 min at a
flow rate of 2 ml/min to yield compounds 1 (5.0 mg; Rt = 21.69), 3
(15.0 mg; Rt = 21.69).
3.5. Evaluation of antioxidant activity
The antioxidant potential of the isolated compounds (3-10) was
evaluated by using DPPH radical scavenging method. Whereas, the
absorbance with various concentrations of the test compounds were
dissolved in MeOH (100 μl) in a 96-well microtiter plate and was
measured at 515 nm as Ablank. Then, 200 μM DPPH solution (100 μl)
was added to each well, followed by incubation in the dark at room
temperature for 30 min. The absorbance was measured again as Asample
.
Trolox was used as positive control with IC50 of 16.6
2.2 μM.
The % inhibition was calculated using the following equation:
% inhibition=[1-(Asample−Ablank)/(Acontrol−Ablank)]×100
Additionally, subraction E-II-2-6 (2.0 g) was rechromatographed on
sephadex LH-20 CC using MeOH, followed by HPLC using H2O-MeOH-
CH3CN (95:4:1) for 5 min, followed by a linear gradient to H2O-MeOH-
CH3CN (10:65:25) within 60 min at a flow rate of 2 ml/min, resulted in
the isolation of compounds 6 (60.0 mg; Rt = 23.07) and 7 (10.0 mg;
Rt = 25.05). While, subraction E-II-2-7 (2.9 g) was subjected to se-
phadex LH-20 CC using MeOH, afforded two subractions. Subfraction E-
II-2-7-a (0.43 g) was recrystallized by MeOH to afford compound 8
(19.5 mg), while E-II-2-7-b (1.9 g) was rechromatographed on reversed
phase (RP18) CC, followed by HPLC purification using H2O–MeOH
(90:10) for 5 min, followed by a linear gradient to 100 % MeOH within
60 min at a flow rate of 2 ml/min., yielded compounds 9 (100.0 mg;
Rt = 27.09), 2 (5.0 mg; Rt = 25.02) and 10 (25.0 mg; Rt = 20.27).
Where Acontrol is the absorbance of the control reaction mixture (con-
taining DMSO and all reagents except for the test compounds and
compounds.
IC50 was determined as the concentration of sample required to
3.6. Human cancer cell growth inhibition assay
This assay was performed using a human lung cancer cell line
(A549) and the viability was estimated by means of the colorimetric
MTT assay. Dulbecco’s modified Eagle medium supplemented with 10
% heat-inactivated FBS and 100 μg/mL of kanamycin was used as the
cell culture medium. The test compounds were dissolved in DMSO at
concentration of 10 mM and then added to the wells of 96-well mi-
crotiter plates to the final concentration of 1 %. A549 cells (5 × 103
cells/well) were cultured in a 5 % CO2 incubator at 37 °C for 72 h and
then a MTT solution was added to each well and the plates were in-
cubated for a further 1.5 h. Then the formazan precipitates were dis-
solved in DMSO and the optical density value for each well was mea-
sured at 540 nm with a microplate reader. Doxorubicin was used as a
3.3.1. Bignanoside A
24
Yellow powder. [α]D +19.37 (c = 0.16, MeOH); IR νmax (film)
cm–1: 3123, 2885, 1557, 1540, 1508, 1455, 1314, 1200, 1081, 1043;
UV λmax (MeOH) nm (log ε): 213 (4.16), 255 (3.94), 350 (3.94), 365
(4.06); 1H-NMR (400 MHz, CD3OD) and 13C-NMR (100 MHz, CD3OD):
Table 1; HR-ESI-MS (positive-ion mode) m/z: 587.2123 [M + Na]+
positive control (IC50: 0.90
The cell growth inhibition was calculated using the following
equation:
0.02 μM).
3.3.2. Bignanoside B
23
Pale yellow amorphous powder. [α]D − 6.0 (c = 0.1, MeOH); IR
% Inhibition = [1 ‒ (Asample ‒ Ablank) / (Acontrol ‒ Ablank)] × 100
νmax (film) cm–1: 3360, 1696 and 1627, 1285, 1164, 1079; UV λmax
(MeOH) nm (log ε): 197 (0.73), 220 (0.11), 242 (0.07) and 332 (0.06);
1H-NMR (500 MHz, CD3OD) and 13C-NMR (125 MHz, CD3OD): Table 2;
HR-ESI-MS (positive-ion mode) m/z: 589.1525 [M + Na]+ (Calcd for
Where Acontrol is the absorbance of the control reaction mixture con-
taining DMSO and all reagents except for the test compound. IC50 was
determined as the concentration of sample required to inhibit the for-
C
26H30O14Na: 589.1533).
3.7. Evaluation of antitrypanosomal activity
3.3.3. (-)-Lyoniresinol 3α-O-α-L-rhamnopyranoside
26
Pale yellow amorphous powder. [α]D −33.3 (c = 0.27, MeOH);
The isolated compounds were tested against Trypanosoma brucei
brucei S427 in the blood stream form. Whereas, samples were initially
screened at a single concentration of 20 μM (n = 3). The pure com-
pounds were prepared as 10 mM stock solution in 100 % DMSO and
diluted with HMI-9 (10 % FBS) medium. Controls included a sterility
control, 0.2 % DMSO and a concentration range of suramin as a positive
control. Suramin gave an antitrypanosomal activity against T. brucei
brucei at an MIC of 0.11 μM. Trypanosomes were counted using a
haemocytometer and diluted to a concentration of 3 × 104 trypano-
somes/mL (HMI-9 (10 % FBS)), 100 μL of this suspension was added to
each well. The assay plate was incubated at 37 °C with a humidified
atmosphere containing 5 % CO2 for 48 h. Then 20 μL of Alamar blue
IR νmax (film) cm–1: 3340, 2800, 1612, 1517, 1500, 1460, 1320, 1208,
1105, 1048, 980, 752; UV λmax (MeOH) nm (log ε): 225 (1.83), 272
(4.54), 283 (4.65); 1H-NMR (400 MHz, CD3OD) and 13C-NMR
(100 MHz, CD3OD): Table 3; HR-ESI-MS (positive-ion mode) m/z:
589.2261 [M + Na]+ (Calcd for C28H38O12Na: 589.2255).
3.4. Analysis of the sugar moiety
About 1 mg of compounds 1–3 were hydrolyzed with 1 M HCl
(1.0 ml) at 80 °C for 2 h. The reaction mixtures were neutralized with
Amberlite IRA96SB (OH−), then partitioned with an equal amount of
EtOAc (1.0 ml), and then water layers were analyzed for their sugar
components. The sugars were evaluated by HPLC on an amino column
[Shodex Asahipak NH2P-50 4E (4.6 mm × 250 mm), CH3CN-H2O (3:1),
1 ml/min], using chiral detector (JASCO OR-2090plus), in comparison
with an authentic sugars (D-glucose and L-rhamnose). Compounds 1
and 2 presented the peak for D-(+)-glucose at retention time of
8.32 min, while compound 3 provided the peak for L-(−)-rhamnose at
retention time of 5.38 min.
was added and the incubation continued for
a further 24 h.
Fluorescence was then determined using a Wallac Victor 2 microplate
reader (Excitation 530 nm Emission 590 nm). The results were calcu-
4. Conclusion
The present study revealed the phytochemical analysis of B. binata
204